Angiotensin I-converting enzyme inhibitory substance
AssigneeRiken Vitamin Co., Ltd.
InventorsMinoru Sato, MinoruTakashi Ooba, Akio Kobayashi, Katsura Funayama, Takashi Kahara, Takahisa Nakano
Life of this patent
Estimating the term…
Loading patent…
AssigneeRiken Vitamin Co., Ltd.
InventorsMinoru Sato, MinoruTakashi Ooba, Akio Kobayashi, Katsura Funayama, Takashi Kahara, Takahisa Nakano
Estimating the term…
The subject of the invention is to produce a peptide with potent the angiotensin I-converting enzyme (ACE) inhibitory activity by decomposing the protein contained in wakame with protease, using wakame being a food material ingested daily as a raw material, and to provide a safe food composition with hypotensive activity, using the treatment product thereof as a raw material. The inventors have found that, when performing the decomposing treatment of wakame with various proteases, a group of endo-type enzymes produced by Bacillus produce peptides with particularly strong ACE inhibitory activity, leading to the completion of the invention.
An angiotensin I-converting enzyme inhibitory substance, containing peptide obtained by decomposing wakame with protease other than pepsin.
A decomposition conduct of protein with blood-pressure lowering activity characterized by containing a peptide with potent an angiotensin I-converting enzyme inhibitory activity wherein said peptide is obtained by decomposing wakame with a protease other than pepsin.
A preparing method of an angiotensin I-converting enzyme inhibitory substance, characterized by decomposing wakame with protease other than pepsin to give a peptide with potent an angiotensin I-converting enzyme inhibitory activity.
Dependencies are inferred from the claim text.